BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 21, 2014
View Archived Issues
Regulus Therapeutics nominates RG-012 as candidate for Alport syndrome
Read More
A novel screening approach to identify disease-associated candidate genes
Read More
New trials evaluate CardioCell's itMSC therapy for acute myocardial infarction
Read More
Vitae Pharmaceuticals earns milestone payment from Boehringer Ingelheim
Read More
Cempra begins phase I trial of solithromycin in a pediatric population
Read More
Raptor Pharmaceutical reports results for RP-103 in Huntington's disease
Read More
Invion and 3M Drug Delivery Systems collaborate on inhaled respiratory drugs
Read More
FDA accepts Merck & Co.'s BLA for V-503 for review
Read More
Anoro receives positive CHMP opinion for the treatment of COPD
Read More
MolecularMD to develop diagnostic test to support CML treatment-free remission trials
Read More
TrpV4 inhibition shows promise as a treatment approach for acute ischemic stroke
Read More
Bristol-Myers Squibb designs new P2Y1 receptor antagonists
Read More
Amgen presents new protein kinase pim inhibitors for cancer
Read More
OncoMed Pharmaceuticals begins third phase Ib trial of OMP-54F28
Read More
Novel agents for thromboembolic disorders patented by Bristol-Myers Squibb
Read More
FDA grants fast track designation to Egalet-001 and Egalet-002
Read More
U.S. and Chinese group prepares new agents for cancer and other disorders
Read More
Japan's MHLW expands approval of Hisamitsu's estradiol transdermal patch
Read More
Kyowa Hakko Kirin obtains additional approval for Regpara tablets in Japan
Read More
T1128C NPY polymorphism identified as a stroke risk factor
Read More
Scientists at Merck & Co. divulge novel GPR40 agonists for diabetes
Read More
Purdue Pharma and Shionogi & Co. patent new NOP receptor ligands
Read More
Patient enrollment is ongoing in a phase II study of GSK-249320
Read More
EMA committee recommends approval of BioMarin's Vimizim for Morquio A syndrome
Read More
Lucentis approved in Japan for diabetic macular edema
Read More
GSK's umeclidinium recommended for E.U. approval in treatment of COPD
Read More
AB Science reports initiation of new phase III study of masitinib plus docetaxel in prostate cancer
Read More